FDA 483 - Nana Barseghian, M.D. - February 16, 2024

I am unable to create a concise summary of the FDA 483 document as the provided content only contains placeholder text for page numbers and lacks any substantive information regarding company name, inspection dates, violations, regulatory framework, or required actions. To generate a summary, please provide the actual content of the FDA 483 document.